This is an HTML version of an attachment to the Official Information request 'Genomic sequencing of first community cases'.

133 Molesworth Street 
PO Box 5013 
19 March 2021
Wellington 6140 
New Zealand 
T+64 4 496 2000 
Ryan Potts 
By email: 
[FYI request #14741 email] 
[email address] 
 [email address] 
Dear Ryan Potts 
Response to your request for official information 
Thank you for your two requests under the Official Information Act 1982 (the Act) to the Ministry 
of Health (the Ministry) on 24 and 25 February 2021 regarding undetected community 
transmission documentation and two locally acquired cases of COVID-19 on 23 March 2020. On 
24 February 2021, Hon Chris Hipkins, Minister for COVID-19 Response transferred a similar 
request under section 14 of the Act. All three requests have been consolidated into one 
response in accordance with section 18(A) of the Act. 
Information in response to each part of your request is as follows. 
“Please disclose any advice and reports to the Director-General concerning the possibility 
of undetected community transmission of Covid-19 in New Zealand since February 2020. 
Provide any advice and reports concerning the possibility of undetected community 
transmission of Covid-19 in New Zealand.” 
“Any advice and reports concerning the possibility of undetected community transmission 
of Covid-19 in New Zealand.” 

The Ministry has been unable to identify any documentation within the scope of this part of your 
request. Your request is therefore refused under section 18(e) of the Act, as the information 
does not exist. 
“Please disclose the findings of any genomic sequencing undertaken on the two cases of 
locally acquired Covid-19 reported by the Director-General on 23 March 2020. Please also 
advise if these cases were linked. If the source of infection could not be identified, please 
comment on whether the Ministry considers this evidence that the first community cases 
in New Zealand were the result of undetected transmission
Information in response to the remainder of your request was provided by the Institute of 
Environmental Science and Research.  
The Wairarapa case yielded a partial genome and is classified as a B lineage. The Auckland 
case yielded a genome and was classified as a B.1.197 lineage. Since the Wairarapa case did 
not yield a complete genome and the Auckland case did, it is therefore impossible to determine 
whether or not the two cases are linked. 
“On 23 March 2020, the Director-General confirmed two locally acquired cases of Covid-

19 in Auckland and the Wairarapa. I request the following information: Was there an 
epidemiological link between these two cases? If so, please disclose further details.” 

No epidemiological link with known cases has been established for either of the two cases. 
“Has genomic sequencing been undertaken to establish the source(s) of these infections? 
If so, please disclose the findings. If no link to other cases was established, does the 
Ministry view this as evidence of undetected community transmission; and if not, why 

Whole genome sequencing was not performed on all cases of COVID-19 detected in New 
Zealand in the early stages of the pandemic, so a lack of genomic link to another case does not 
rule out the possibility that other gnomically similar cases were present.  
The case definition is reviewed regularly and at the time these cases were detected, individuals 
who were being prioritised for testing were those with a fever of more than 38°C or any acute 
respiratory infection with at least one of the following symptoms: shortness of breath, cough or 
sore throat with or without fever. 
I trust this information fulfils your request. Under section 28(3) of the Act you have the right to 
ask the Ombudsman to review any decisions made under this request. The Ombudsman may 
be contacted by email at: [email address] or by calling 0800 802 602. 
Please note that this response, with your personal details removed, may be published on the 
Ministry website at:
Yours sincerely 
Dom Harris 
Manager Office of the Deputy Chief Executive 
COVID-19 Health System Response
Page 2 of 2